Antitumour immunoprotection by an immunobacterial lectin approach.
D000117:Acetylglucosamine / Q000276:immunology; D000818:Animals; D000917:Antibody Formation; D000942:Antigens, Bacterial / Q000008:administration & dosage* / Q000633:toxicity; D001835:Body Weight; D002286:Carcinoma, Ehrlich Tumor / Q000517:prevention & control*; D002462:Cell Membrane / Q000276:immunology; D002686:Chitin; D004306:Dose-Response Relationship, Immunologic; D007115:Immunization Schedule; D007939:Leukemia L1210 / Q000517:prevention & control*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008815:Mice, Inbred Strains; D008837:Micrococcus / Q000276:immunology; D014611:Vaccination
D000942:Antigens, Bacterial; D002686:Chitin; D000117:Acetylglucosamine